Flamel Technologies S.A. (ADR) (NASDAQ:FLML)
CAPS Rating:
A biopharmaceutical company principally engaged in the development of two unique polymer-based drug delivery technologies for the improvement of medical applications.
RSS Headlines
Fool UK
Recs
Investing is a risky proposition.